Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Laurus Labs Limited
LAURUSLABSLaurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
Analytics
Objectif de Cours de WallStreet
47 253.13 INRRatio C/B
203.8163Rendement du dividende
0.17 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés LAURUSLABS
Analyse des dividendes LAURUSLABS
Croissance des dividendes sur 5 ans
433 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
37 %Historique des dividendes LAURUSLABS
Valorisation des titres LAURUSLABS
financières LAURUSLABS
Résultats | 2019 | Dynamique |